69269-830 : Obagi 4.03 mg/57g Topical Cream
| NDC: | 69269-830 |
| Labeler: | Ys Plus Corporation |
| Product Type: | Human OTC Drug |
| Drug Name: | Obagi |
| Dosage Form: | Topical Cream |
| Rev. Date: |
NDC Package Codes:
- 69269-830-01: 57 G IN 1 BOTTLE (69269‑830‑01)
Active Ingredients:
- Arbutin
Dosage Strength:
- 4.03 mg/57g
Related Products:
Based on records with the same trade name.- 69269-103 Obagi Topical Lotion by Ys Plus Corporation
- 69269-104 Obagi Topical Lotion by Ys Plus Corporation
- 69269-107 Obagi Topical Lotion by Ys Plus Corporation
- 69269-108 Obagi Topical Lotion by Ys Plus Corporation
- 69269-110 Obagi 20 mg/ml Topical Gel by Ys Plus Corporation
- 69269-111 Obagi 20 mg/ml Topical Gel by Ys Plus Corporation
- 69269-113 Obagi 50 mg/ml Topical Lotion by Ys Plus Corporation
- 69269-114 Obagi 200 mg/ml Topical Cream by Ys Plus Corporation
- 69269-121 Obagi Topical Cream by Ys Plus Corporation
- 69269-125 Obagi Topical Lotion by Ys Plus Corporation
- 69269-126 Obagi Topical Cream by Ys Plus Corporation
- 69269-128 Obagi Topical Lotion by Ys Plus Corporation
- 69269-129 Obagi 20 mg/ml Topical Gel by Ys Plus Corporation
- 69269-130 Obagi Topical Lotion by Ys Plus Corporation
- 69269-131 Obagi Topical Lotion by Ys Plus Corporation
- 69269-200 Obagi Topical Cream by Ys Plus Corporation
- 69269-300 Obagi Topical Cream by Ys Plus Corporation
- 69269-415 Obagi .5 mg/g Topical Cream by Ys Plus Corporation
- 69269-416 Obagi 1 mg/g Topical Cream by Ys Plus Corporation
- 69269-511 Obagi Kit by Ys Plus Corporation
- More related products ...
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 69269-820Next: 69269-831 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.
